HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study Links Triclosan To Bacterial Colonization, Staph Infection Risks

This article was originally published in The Tan Sheet

Executive Summary

Researchers identified a positive correlation between triclosan’s presence in nasal secretions and colonization of Staphylococcus aureus, a risk factor for potentially deadly infections. The findings “suggest that a reevaluation of triclosan in consumer products is urgently needed,” according to their study.

You may also be interested in...



FDA Says Antiseptics Need Testing Or Face Reformulation, Relabeling

FDA proposes to amend the OTC antiseptic drug product monograph to require more detailed safety and efficacy tests, pointing to mounting data that shows antibacterial wash products could pose health risks and contribute to increase antibacterial resistance.

Amyris Announces Gen Z-Focused EcoFabulous As Latest Acquisition In $12m Portfolio Enrichment

Brands under development and recent acquisitions including EcoFabulous, Costa Brazil and Terasana will account for around 20% of overall 2021 revenue in Amyris’ Consumer business, according to the firm, which aspires to be the “L’Oreal of clean beauty.”

J&J, Symrise Invest In Sunday II Sunday Hair Care For Active Women With Textured Hair

Johnson & Johnson Innovation led a $4.2m Series A financing announced on 25 March, which will help to build out Sunday II Sunday’s hair-care product offering and support in-store distribution in months to come.

Topics

UsernamePublicRestriction

Register

RS139374

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel